Identification of a serotonin/glutamate receptor complex implicated in psychosis
Open accessThe DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
Abstract
The psychosis associated with schizophrenia is characterized by alterations in sensory processing and perception. Some antipsychotic drugs were identified by their high affinity for serotonin 5-HT2A receptors (2AR). Drugs that interact with metabotropic glutamate receptors (mGluR) also have potential for the treatment of schizophrenia. The effects of hallucinogenic drugs, such as psilocybin and lysergic acid diethylamide, require the 2AR and resemble some of the core symptoms of schizophrenia. Here we show that the mGluR2 interacts through specific transmembrane helix domains with the 2AR, a member of an unrelated G-protein-coupled receptor family, to form functional complexes in brain cortex. The 2AR-mGluR2 complex triggers unique cellular responses when targeted by hallucinogenic drugs, and activation of mGluR2 abolishes hallucinogen-specific signalling and behavioural responses. In post-mortem human brain from untreated schizophrenic subjects, the 2AR is upregulated and the mGluR2 is downregulated, a pattern that could predispose to psychosis. These regulatory changes indicate that the 2AR-mGluR2 complex may be involved in the altered cortical processes of schizophrenia, and this complex is therefore a promising new target for the treatment of psychosis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Furthermore, the 5HT2A receptor forms a functional heterodimer with the mGluR2 receptor, which evokes allosteric effects on serotonin agonist binding [34];”
From Molecular and Functional Imaging Studies of Psychedelic Drug Action in Animals and Humans. (2021) · cites this paper as [34]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“this interaction reduces the hallucinogen-specific Gi/o protein signaling and behavior and may account for the lack of hallucinogenic action of 2-bromo-LSD (5) noted above.”
From Molecular and Functional Imaging Studies of Psychedelic Drug Action in Animals and Humans. (2021) · cites this paper as [34]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Temporal pattern encoding relieves the cellular information bottleneck, where many stimuli must signal through few intracellular pathways to generate diverse and specific cellular responses (30 -32) but complicates the relationship between synthetic target modulators and their cellular and clinical effects.”
From Cytokine Response Is Determined by Duration of Receptor and Signal Transducers and Activators of Transcription 3 (STAT3) Activation (2013) · cites this paper as [31]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Several recent studies of drugs acting at cell surface receptor targets show that the activation mechanisms responsible for their cellular and systemic effects are more complex than accounted for by their classical pharmacological profiles (30 -32).”
From Cytokine Response Is Determined by Duration of Receptor and Signal Transducers and Activators of Transcription 3 (STAT3) Activation (2013) · cites this paper as [31]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Diagnostic and Statistical Manual of Mental Disorders
Williams, J. B. W., & First, M. (2013) · Encyclopedia of Social Work · doi:10.1093/acrefore/9780199975839.013.104 · Cited by 109,519
Basic local alignment search tool
Altschul, S. F., Gish, W., Miller, W., Myers, E. W., & Lipman, D. J. (1990) · Journal of Molecular Biology · doi:10.1006/jmbi.1990.9999 · Cited by 98,669
Thompson, J. D., Higgins, D. G., & Gibson, T. J. (1994) · Nucleic Acids Research · doi:10.1093/nar/22.22.4673 · Cited by 64,617
Comparative Protein Modelling by Satisfaction of Spatial Restraints
Šali, A., & Blundell, T. L. (1993) · Journal of Molecular Biology · doi:10.1006/jmbi.1993.1626 · Cited by 12,977
Crystal Structure of Rhodopsin: A G Protein-Coupled Receptor
Palczewski, K., Kumasaka, T., Hori, T., Behnke, C. A., Motoshima, H., Fox, B. A., Trong, I. L., Teller, D. C., Okada, T., Stenkamp, R. E., et al. (2000) · Science · doi:10.1126/science.289.5480.739 · Cited by 5,637
High-Resolution Crystal Structure of an Engineered Human β 2 -Adrenergic G Protein–Coupled Receptor
Cherezov, V., Rosenbaum, D. M., Hanson, M. A., Rasmussen, S. G. F., Thian, F. S., Kobilka, T. S., Choi, H.-J., Kuhn, P., Weis, W. I., Kobilka, B. K., et al. (2007) · Science · doi:10.1126/science.1150577 · Cited by 3,264
Patil, S. T., Zhang, L., Martenyi, F., Lowe, S. L., Jackson, K. A., Andreev, B. V., Avedisova, A. S., Bardenstein, L. M., Gurovich, I. Y., Morozova, M. A., et al. (2007) · Nature Medicine · doi:10.1038/nm1632 · Cited by 1,040
Psilocybin induces schizophrenia-like psychosis in humans via a serotonin-2 agonist action
Vollenweider, F. X., Vollenweider-Scherpenhuyzen, M. F. I., Bäbler, A., Vogel, H., & Hell, D. (1998) · NeuroReport · doi:10.1097/00001756-199812010-00024 · Cited by 1,018
Miyamoto, S., Duncan, G. E., Marx, C. E., & Lieberman, J. A. (2005) · Molecular Psychiatry · doi:10.1038/sj.mp.4001556 · Cited by 988
González-Maeso, J., Weisstaub, N. V., Zhou, M., Chan, P., Ivic, L., Ang, R., Lira, A., Bradley-Moore, M., Ge, Y., Zhou, Q., et al. (2007) · Neuron · doi:10.1016/j.neuron.2007.01.008 · Cited by 925
Self-citation
Cited by
Items 401–500 of 835
Buchborn, T., Schröder, H., Dieterich, D. C., Grecksch, G., & Höllt, V. (2014) · Behavioural Brain Research · doi:10.1016/j.bbr.2014.12.014 · Cited by 33
Tsunoka, T., Kishi, T., Kitajima, T., Okochi, T., Okumura, T., Yamanouchi, Y., Kinoshita, Y., Kawashima, K., Naitoh, H., Inada, T., et al. (2010) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2010.03.002 · Cited by 31
“This was supported by evidence from a postmortem study using schizophrenia patients untreated by antipsychotics, who showed increased 5-HT2A and decreased mGluR2 in the cortex compared with age and gender match control samples (Gonzalez-Maeso et al., 2008).”
Evidence for altered post-receptor modulation of the serotonin 2a receptor in schizophrenia
Dean, B., Crossland, N., Boer, S., & Scarr, E. (2008) · Schizophrenia Research · doi:10.1016/j.schres.2008.06.011 · Cited by 32
“Notably, our data and that of earlier studies (Dean, 2003) are not consistent with the recent study reporting heterodimerisation of the HTR2A with the GluR2, which suggest there are increased levels of the receptor in the cortex of subjects with schizophrenia (Gonzalez-Maeso et al., 2008).”
BackgroundResultUslaner, J. M., Smith, S. M., Huszar, S. L., Pachmerhiwala, R., Hinchliffe, R. M., Vardigan, J. D., & Hutson, P. H. (2009) · Psychopharmacology · doi:10.1007/s00213-009-1644-y · Cited by 30
“Furthermore, a recent report suggests that mGlu2 and 5-HT2A receptors are not only coexpressed in the same cortical neurons, but may also form a heterodimer complex (Gonzalez-Maeso et al. 2008).”
Ago, Y., Araki, R., Yano, K., Kawasaki, T., Chaki, S., Nakazato, A., Onoe, H., Hashimoto, H., Baba, A., Takuma, K., et al. (2012) · Journal of Pharmacological Sciences · doi:10.1254/jphs.11200sc · Cited by 29
New Paradigms of Old Psychedelics in Schizophrenia
Mahmood, D., Alenezi, S. K., Anwar, M. J., Azam, F., Qureshi, K. A., & Jaremko, M. (2022) · Pharmaceuticals · doi:10.3390/ph15050640 · Cited by 29
“Hallucinogenic and non-hallucinogenic psychedelic agonists acting via 5-HT2A receptors, such as LSD and lisuride, are distinct in activating intracellular second messenger systems in cortical neurons [179], and it was observed that only psychedelics such as LSD and DOI, which are specifically the hallucinogenic agonis…”
BackgroundCBD and the 5-HT1A receptor: A medicinal and pharmacological review
Alexander, C., Jeon, J., Nickerson, K., Hassler, S. N., & Vasefi, M. (2025) · Biochemical Pharmacology · doi:10.1016/j.bcp.2025.116742 · Cited by 30
Preclinical models of antipsychotic drug action
Moreno, J. L., & González‐Maeso, J. (2013) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145713000606 · Cited by 29
Self-citationBenvenga, M. J., Chaney, S. F., Baez, M., Britton, T. C., Hornback, W. J., Monn, J. A., & Marek, G. J. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.00208 · Cited by 31
“Previous studies have shown that orthosteric mGlu2/3 receptor agonists suppress 2,5-dimethoxy-4-iodoamphetamine (DOI)-induced head twitches in both rats and mice (Gewirtz and Marek, 2000; Klodzinska et al., 2002; Gonzalez-Maeso et al., 2008; Moreno et al., 2011, 2012; Wieronska et al., 2013).”
BackgroundDíez-Alarcia, R., Muguruza, C., Rivero, G., García‐Bea, A., Gómez‐Vallejo, V., Callado, L. F., Llop, J., Martín, A., & Meana, J. J. (2021) · Translational Psychiatry · doi:10.1038/s41398-021-01430-7 · Cited by 30
Self-citationde Bartolomeis, A., Ciccarelli, M., Simone, G. D., Mazza, B., Barone, A., & Vellucci, L. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24065945 · Cited by 32
Marek, G. J., & Zhang, C. (2008) · Neuroscience Letters · doi:10.1016/j.neulet.2008.06.083 · Cited by 31
Persistent effects of chronic clozapine on the cellular and behavioral responses to LSD in mice
Moreno, J. L., Holloway, T. D., Umali, A., Rayannavar, V., Sealfon, S. C., & González‐Maeso, J. (2012) · Psychopharmacology · doi:10.1007/s00213-012-2809-7 · Cited by 31
“These doses were selected based on previous findings with clozapine, haloperidol, and LSD in rodent models (Kuoppamaki et al. 1993; Kontkanen et al. 2002a, b; Gonzalez-Maeso et al. 2008; Gray et al. 2009).”
Self-citationOlivero, G., Grilli, M., Vergassola, M., Bonfiglio, T., Padolecchia, C., Garrone, B., Giorgio, F. P. D., Tongiani, S., Usai, C., Marchi, M., et al. (2018) · Neuropharmacology · doi:10.1016/j.neuropharm.2018.02.030 · Cited by 29
Mora, S., Merchán, A., Vilchez, O., Aznar, S., Klein, A. B., Ultved, L., Campa, L., Sunol, C. E., Flores, P., & Moreno, M. (2018) · Neuropharmacology · doi:10.1016/j.neuropharm.2018.09.004 · Cited by 31
FRET spectroscopy—towards effective biomolecular probing
Obeng, E. M., Dullah, E. C., Danquah, M. K., Budiman, C., & Ongkudon, C. M. (2016) · Analytical Methods · doi:10.1039/c6ay00950f · Cited by 29
Biased agonism and allosteric modulation of metabotropic glutamate receptor 5
Trinh, P. N. H., May, L. T., Leach, K., & Gregory, K. J. (2018) · Clinical Science · doi:10.1042/cs20180374 · Cited by 29
Hibicke, M., Kramer, H. M., & Nichols, C. D. (2023) · Psychedelic Medicine · doi:10.1089/psymed.2022.0012 · Cited by 29
Genetic Rat Models of Schizophrenia-Relevant Symptoms
Río-Álamos, C., Oliveras, I., Cañete, T., Blázquez, G., Tobeña, A., & Fernández‐Teruel, A. (2014) · World Journal of Neuroscience · doi:10.4236/wjns.2014.43030 · Cited by 31
“[5] [7]) to study the relevance of the 5-HT2A/mGluR2 complex in schizophrenia-relevant features (see reviews by [2] [3] [5] [7]).”
BackgroundHuang, M., Dai, J., & Meltzer, H. Y. (2010) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2010.10.094 · Cited by 30
Brugarolas, M., Navarro, G., Martínez‐Pinilla, E., Angelats, E., Casadó, V., Lanciego, J. L., & Franco, R. (2014) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.12277 · Cited by 32
Serotonin and Female Psychopathology
Hall, E., & Steiner, M. S. (2013) · Women s Health · doi:10.2217/whe.12.64 · Cited by 35
Synthesis toward Bivalent Ligands for the Dopamine D2 and Metabotropic Glutamate 5 Receptors
Qian, M., Wouters, E., Dalton, J. A. R., Risseeuw, M., Crans, R. A. J., Stove, C. P., Giraldo, J., Craenenbroeck, K. V., & Calenbergh, S. V. (2018) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.8b00671 · Cited by 30
Thibado, J. K., Tano, J., Lee, J., Salas-Estrada, L. A., Provasi, D., Strauss, A., Ribeiro, J. M. L., Xiang, G., Broichhagen, J., Filizola, M., et al. (2021) · eLife · doi:10.7554/elife.67027 · Cited by 29
“Thus, unlike their full-length counterparts which both show strict dimerization (Levitz et al., 2016), mGluR2-TMD and mGluR3-TMD show distinct dimerization propensities that are less than an obligate dimer but greater than a canonical class A GPCR, β2AR, which we used as a monomeric or weak dimerization control (Figur…”
BackgroundInfluentialSelf-citationFernández‐Teruel, A., Oliveras, I., Cañete, T., Río-Álamos, C., Tapias-Espinosa, C., Sampedro-Viana, D., Sánchez-González, A., Sanna, F., Torrúbia, R., González‐Maeso, J., et al. (2021) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2021.09.042 · Cited by 29
Self-citationPsilocybin-induced default mode network hypoconnectivity is blunted in alcohol-dependent rats
Reinwald, J., Schmitz, C. N., Skorodumov, I., Kuchař, M., Weber‐Fahr, W., Spanagel, R., & Meinhardt, M. W. (2023) · Translational Psychiatry · doi:10.1038/s41398-023-02690-1 · Cited by 28
Pałucha-Poniewiera, A., Brański, P., Wierońska, J. M., Stachowicz, K., Sławińska, A., & Pilc, A. (2013) · Psychopharmacology · doi:10.1007/s00213-013-3206-6 · Cited by 30
Pathophysiology of GPCR Homo- and Heterodimerization: Special Emphasis on Somatostatin Receptors
Somvanshi, R. K., & Kumar, U. (2012) · Pharmaceuticals · doi:10.3390/ph5050417 · Cited by 30
“Psychosis/Schizophrenia: Modulation of the 5-HT and glutamate receptor functional complex has been shown to play critical role in inclining schizophrenic patients to psychosis [181].”
BackgroundCurrent and Future Challenges in GPCR Drug Discovery
Topiol, S. (2017) · Methods in molecular biology · doi:10.1007/978-1-4939-7465-8_1 · Cited by 29
Functional characterization of G-protein-coupled receptors: A bioinformatics approach
Tovo‐Rodrigues, L., Roux, A., Hutz, M. H., Rohde, L. A., & Woods, A. S. (2014) · Neuroscience · doi:10.1016/j.neuroscience.2014.06.049 · Cited by 30
Adrenergic control of lymphocyte trafficking and adaptive immune responses
Nakai, A., & Suzuki, K. (2018) · Neurochemistry International · doi:10.1016/j.neuint.2018.10.017 · Cited by 26
Probing the cooperative mechanism of the μ–δ opioid receptor heterodimer by multiscale simulation
Wang, L., Yuan, Y., Chen, X., Chen, J., Guo, Y., Li, M., Li, C., & Pu, X. (2018) · Physical Chemistry Chemical Physics · doi:10.1039/c8cp06652c · Cited by 26
Zhao, X., Ozols, A. B., Meyers, K. T., Campbell, J. M., McBride, A., Marballi, K. K., Maple, A. M., Raskin, C., Mishra, A. P., Noss, S., et al. (2022) · Molecular Psychiatry · doi:10.1038/s41380-021-01390-w · Cited by 26
“While some studies did not detect differences [9–11], and one group identified increased levels [12, 13], the vast majority of these studies, including a meta-analysis [14], have revealed reduced 5-HT2AR levels in schizophrenia subjects.”
Bono, F., Fiorentini, C., Mutti, V., Tomasoni, Z., Sbrini, G., Trebesova, H., Marchi, M., Grilli, M., & Missale, C. (2023) · Pharmacological Research · doi:10.1016/j.phrs.2023.106711 · Cited by 26
“To date, the relevance of GPCRs heteromers in the pathogenesis of various diseases has been described [19,20,33], including pre-eclampsia [34,35], asthma [36], acquired immune deficiency syndrome [37], heart failure [38], liver fibrosis [39], schizophrenia [40,41] and Parkinson ’ s Disease (PD).”
Asymmetric activation of dimeric GABAB and metabotropic glutamate receptors
Liu, L., Li, L., Shen, C., Rondard, P., Pin, J., Xu, C., & Liu, J. (2023) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00150.2022 · Cited by 26
Do the therapeutic effects of psilocybin involve actions in the gut?
Reed, F. M., & Foldi, C. J. (2024) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2023.12.007 · Cited by 28
Bhattacharya, A., Sankar, S., & Panicker, M. M. (2009) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2009.06493.x · Cited by 26
Fasciani, I., Petragnano, F., Aloisi, G., Marampon, F., Carli, M., Scarselli, M., Maggio, R., & Rossi, M. (2020) · Pharmaceuticals · doi:10.3390/ph13110388 · Cited by 27
Genetically encoded fluorescent biosensors for GPCR research
Kim, H., Baek, I.-Y., & Seong, J. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.1007893 · Cited by 26
“, 2016), and some GPCR oligomerization populations may be related to disease states (Ferre et al., 1991; Jordan et al., 2003; Gonzalez-Maeso et al., 2008).”
BackgroundWoźniak, M., Gołembiowska, K., Noworyta, K., Acher, F., Cieślik, P., Kusek, M., Tokarski, K., Pilc, A., & Wierońska, J. M. (2016) · Neuropharmacology · doi:10.1016/j.neuropharm.2016.06.025 · Cited by 25
Diversity of Metabotropic Glutamate Receptor–Interacting Proteins and Pathophysiological Functions
Fagni, L. (2012) · Advances in experimental medicine and biology · doi:10.1007/978-3-7091-0932-8_3 · Cited by 27
Chang, C.-W., Poteet, E. C., Schetz, J. A., Gumus, Z. H., & Weinstein, H. (2008) · Neuropharmacology · doi:10.1016/j.neuropharm.2008.07.049 · Cited by 27
“, 2007), and functional hetero-oligomerization (Gonzalez-Maeso et al., 2008).”
BackgroundSingh, N., Hazari, P. P., Mittal, P., Yadav, S. K., Kumar, N., Mishra, G., Dahiya, S., & Mishra, A. K. (2025) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2025.177737 · Cited by 24
Psychedelics elicit their effects by 5-HT2A receptor-mediated Gi signalling
Xu, Z., Wang, H., Yu, J., Deng, Y., Tian, X., Ni, R., Xia, F., Yang, L., Xu, C., Zhang, L., et al. (2026) · Nature · doi:10.1038/s41586-025-10061-7 · Cited by 27
History and Biological Significance of GPCR Heteromerization in the Neuroendocrine System
Tadagaki, K., Jockers, R., & Kamal, M. T. (2011) · Neuroendocrinology · doi:10.1159/000330000 · Cited by 30
Brown, S. M., Bush, S. J., SUMMERS, K. M., Hume, D. A., & Lawrence, A. B. (2018) · Behavioural Brain Research · doi:10.1016/j.bbr.2018.05.015 · Cited by 25
Domanegg, K., Sommer, W. H., & Meinhardt, M. W. (2023) · Cells · doi:10.3390/cells12060963 · Cited by 24
Richtand, N. M., Ahlbrand, R., Horn, P. S., Tambyraja, R., Grainger, M., Bronson, S. L., & McNamara, R. K. (2012) · Physiology & Behavior · doi:10.1016/j.physbeh.2012.02.004 · Cited by 26
“As functional and physical connections between glutamate mGluR2 receptors and serotonin 5-HT2A receptors have previously been described [67], serotonergic effects of fluoxetine and aripiprazole may contribute to the observed outcome.”
Szafran‐Pilch, K., Faron‐Górecka, A., Kolasa, M., Kuśmider, M., Solich, J., Żurawek, D., & Dziedzicka‐Wasylewska, M. (2013) · Pharmacological Reports · doi:10.1016/s1734-1140(13)71510-x · Cited by 24
“It was proposed that the dysregulation in expression levels of these receptors could predispose an individual to schizophrenia [6].”
BackgroundHDAC2 as a new target to improve schizophrenia treatment
Kurita, M., Holloway, T. D., & González‐Maeso, J. (2013) · Expert Review of Neurotherapeutics · doi:10.1586/ern.12.141 · Cited by 25
Self-citationIbi, D., & Yamada, K. (2015) · International Journal of Molecular Sciences · doi:10.3390/ijms161226092 · Cited by 30
Lladó-Pelfort, L., Troyano‐Rodriguez, E., van den Munkhof, H. E., Cervera‐Ferri, A., Jurado, N., Núñez-Calvet, M., Artigas, F., & Celada, P. (2015) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2015.11.015 · Cited by 24
“Alternatively, LY379268 might evoke its effects through 5-HT2A/mGluR2 heterodimers (González-Maeso et al., 2008).”
BackgroundGarcía‐Bea, A., Walker, M. A., Hyde, T. M., Kleinman, J. E., Harrison, P. J., & Lane, T. A. (2016) · Schizophrenia Research · doi:10.1016/j.schres.2016.04.015 · Cited by 25
Tapias-Espinosa, C., Río-Álamos, C., Sampedro-Viana, D., Gerbolés, C., Oliveras, I., Sánchez-González, A., Tobeña, A., & Fernández‐Teruel, A. (2018) · Behavioural Processes · doi:10.1016/j.beproc.2018.03.019 · Cited by 27
Siddique, S. A., Tamilselvan, T., Vishnupriya, M., & Balamurugan, E. (2018) · Neurochemical Research · doi:10.1007/s11064-018-2533-8 · Cited by 24
Marek, G. J. (2009) · Neuropharmacology · doi:10.1016/j.neuropharm.2009.03.005 · Cited by 25
“, 2000), and (3) the suggestion that 5-HT2A and mGlu2 receptors interact via a molecular complex (Gonzalez-Maeso et al., 2008), then the presence or absence of a molecular complex between 5-HT2A and adenosine A1 receptors may be important for evaluating this new theory postulated to explain physiological interactions…”
BackgroundWierońska, J. M., & Pilc, A. (2019) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2018.08.010 · Cited by 23
Shah, U. H., Toneatti, R., Gaitonde, S. A., Shin, J. M., & González‐Maeso, J. (2020) · Cell chemical biology · doi:10.1016/j.chembiol.2020.07.006 · Cited by 23
Self-citationComputational Approaches for Modeling GPCR Dimerization
Meng, X.-Y., Mezei, M., & Cui, M. (2014) · Current Pharmaceutical Biotechnology · doi:10.2174/1389201015666141013102515 · Cited by 27
“Heterodimeric complex of the metabotropic glutamate receptor type-2 (mGluR2) and 5HT 2A serotoninergic receptor (2AR) has been reported to be a new target for the treatment of psychosis and shows distinct functional behavior from their monomer 46 .”
BackgroundFuxé, K., Marcellino, D. J., Guidolin, D., Woods, A. S., & Agnati, L. F. (2009) · Journal of Acupuncture and Meridian Studies · doi:10.1016/s2005-2901(09)60011-x · Cited by 26
G protein-coupled receptor oligomerization for what?
Ciruela, F., Vallano, A., Arnau, J. M., Sánchez, S., Borroto‐Escuela, D. O., Agnati, L. F., Fuxé, K., & Fernández‐Dueñas, V. (2010) · Journal of Receptors and Signal Transduction · doi:10.3109/10799893.2010.508166 · Cited by 23
“serotonin 5-HT2A/metabotropic glutamate receptor 2 heterodimer.(45)”
Dziedzicka‐Wasylewska, M., Faron‐Górecka, A., Górecki, A., & Kuśemider, M. (2008) · PubMed · Cited by 28
Kolber, B. J. (2015) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2014.12.003 · Cited by 25
Hazama, K., Hayata‐Takano, A., Uetsuki, K., Kasai, A., Encho, N., Shintani, N., Nagayasu, K., Hashimoto, R., Reglődi, D., Miyakawa, T., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0089153 · Cited by 22
“The suppression of this system by activation of the metabotropic glutamate receptor 2 has been shown to abolish the hallucinogen-specific signaling and behavioral responses [33].”
Novel approaches to drug design for the treatment of schizophrenia
Taly, A. (2013) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.2013.821108 · Cited by 23
“It should be noted that mGluR2 receptors have been found to interact with 5-HT2A receptors [49].”
BackgroundOliveras, I., Sánchez-González, A., Sampedro-Viana, D., Piludu, M. A., Río-Álamos, C., Giorgi, O., Corda, M. G., Aznar, S., González‐Maeso, J., Gerbolés, C., et al. (2017) · Psychopharmacology · doi:10.1007/s00213-017-4534-8 · Cited by 25
“Thus, because of their dramatic deficit of mGlu2 receptors (Klein et al. 2014), RHA-I rats would be expected to display weaker effects of 5- HT2A-receptor ligands on PPI as compared with their RLA-I counterparts (Gonzalez-Maeso et al. 2008; Fribourg et al. 2011).”
BackgroundResultInfluentialSelf-citationVargas-Pérez, H., Grieder, T. E., Ting‐A‐Kee, R. A., Maal‐Bared, G., Chwalek, M., & van der Kooy, D. (2017) · European Journal of Neuroscience · doi:10.1111/ejn.13572 · Cited by 23
Hámor, P. U., Šírová, J., Páleníček, T., Zaniewska, M., Bubeníková‐Valešová, V., & Schwendt, M. (2018) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2018.09.007 · Cited by 22
“As described below, the rationale for investigating 5-HT2A-mGlu2 receptor-receptor interaction is the proposed role of this receptor heterocomplex in psychosis and in mediating the effects of hallucinogens, including 5-HT2A receptor agonists (González-Maeso et al., 2008; Moreno et al., 2011).”
BackgroundInfluentialHalberstadt, A. L., van der Zee, J. V. F., Chatha, M., Geyer, M. A., & Powell, S. B. (2018) · Psychopharmacology · doi:10.1007/s00213-018-5118-y · Cited by 24
Matrisciano, F., Dong, E., Nicoletti, F., & Guidotti, A. (2018) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2018.00423 · Cited by 24
Kwan, C., Frouni, I., Nuara, S. G., Belliveau, S., Kang, W., Hamadjida, A., Bédard, D., Beaudry, F., Panisset, M., Gourdon, J. C., et al. (2021) · Neuropharmacology · doi:10.1016/j.neuropharm.2021.108465 · Cited by 22
GPCR signaling: role in mediating the effects of early adversity in psychiatric disorders
Tiwari, P., Fanibunda, S. E., Kapri, D., Vasaya, S., Pati, S., & Vaidya, V. A. (2021) · FEBS Journal · doi:10.1111/febs.15738 · Cited by 23
Cannabis use selectively modulates circulating biomarkers in the blood of schizophrenia patients
Ibarra‐Lecue, I., Unzueta‐Larrinaga, P., Barrena-Barbadillo, R., Villate, A., Horrillo, I., Mendivil, B., Landabaso, M. A., Meana, J. J., Etxebarría, N., Callado, L. F., et al. (2022) · Addiction Biology · doi:10.1111/adb.13233 · Cited by 25
“The enhanced 5-HT2AR protein expression agrees with the vast majority of previous literature carried out in platelets as well as with some studies in postmortem brain of subjects with schizophrenia.(18,23) Importantly, all the schizophrenia subjects included in our study were under treatment with antipsychotics, and t…”
ResultSelf-citationDuncan, J. R. (2012) · ISRN Neurology · doi:10.5402/2012/972607 · Cited by 26
“Heterooligomeric complexes have been shown to exist between dopamine D2 and mGlu5 receptors [99], mGlu5 and NDMA receptors [100], serotonin (5-HT)2A and mGlu2 receptors [101], and mGlu5 and GABA(A)α1 receptors [102] as well as other combinations including adenosine A2A [103], μ-opioid [104], or estrogen [105].”
BackgroundFerré, S., Woods, A. S., Navarro, G., Aymerich, M., Lluís, C., & Franco, R. (2009) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2009.10.002 · Cited by 22
Jørgensen, C. V., Jacobsen, J. P. R., Caron, M. G., Klein, A. B., Knudsen, G. M., & Mikkelsen, J. D. (2013) · Neuroscience Letters · doi:10.1016/j.neulet.2013.08.073 · Cited by 23
“The two receptors form heteromeric complexes [13] and activation of mGluR2 inhibits 5-HT2A receptor signalling [26].”
BackgroundInfluentialIglesias, A., Cimadevila, M., Cadavid, M. I., Loza, M. I., & Brea, J. M. (2017) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2017.02.028 · Cited by 22
Sampedro-Viana, D., Cañete, T., Sanna, F., Soley, B., Giorgi, O., Corda, M. G., Torrecilla, P., Oliveras, I., Tapias-Espinosa, C., Río-Álamos, C., et al. (2021) · Behavioural Processes · doi:10.1016/j.beproc.2021.104397 · Cited by 22
5-HT2A receptor dysregulation in a schizophrenia relevant mouse model of NMDA receptor hypofunction
Nakao, K., Singh, M., Sapkota, K., Fitzgerald, A., Hablitz, J. J., & Nakazawa, K. (2022) · Translational Psychiatry · doi:10.1038/s41398-022-01930-0 · Cited by 22
“Since up-regulation of 5-HT2ARs in pyramidal neurons has been proposed as a common neural mechanism that could predispose to psychosis [77, 78], the Grin1 mutant mouse can be a suitable model for research into the pathophysiology of psychosis in schizophrenia and other types of psychotic disorders.”
BackgroundPilc, A., Machaczka, A., Kawalec, P., Smith, J. L., & Witkin, J. M. (2022) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2022.2111415 · Cited by 21
“The fact that 5-HT2A receptors and mGlu2 receptors can form heterocomplexes [157], might provide another clue to the development of dual-receptor antagonism to achieve robust antidepressant effect.”
BackgroundTaddeucci, A., Olivero, G., Roggeri, A., Milanese, C., Giorgio, F. P. D., Grilli, M., Marchi, M., Garrone, B., & Pittaluga, A. (2022) · Cells · doi:10.3390/cells11193035 · Cited by 21
“The immunoprecipitate was positive for both the mGlu2 and the 5-HT2A receptor proteins, well in line with the data in literature [11,12].”
BackgroundResultInfluentialRole of interaction of mGlu2 and 5-HT2A receptors in antipsychotic effects
Ibi, D. (2022) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2022.173474 · Cited by 21
Chen, Y., Liu, J., Yao, Y., Yan, H., & Su, R. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1021729 · Cited by 24
“In contrast, early growth response-2 (Egr-2) induction is a downstream event of a Gi/ o-dependent pathway, which is selectively activated by psychedelics (González-Maeso et al., 2003; Gonzalez-Maeso et al., 2007; González-Maeso et al., 2008).”
BackgroundMorgan, D., Kondabolu, K., Kuipers, A., Sakhuja, R., Robertson, K. L., Rowland, N. E., & Booth, R. G. (2013) · Neuropharmacology · doi:10.1016/j.neuropharm.2013.04.051 · Cited by 23
Ilter, M., Mansoor, S., & Şensoy, Ö. (2019) · Molecules · doi:10.3390/molecules24112052 · Cited by 22
Davis, J. M., Zamora, D., Horowitz, M. S., & Leucht, S. (2021) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2021.1942455 · Cited by 21
Elsilä, L. V., Harkki, J., Enberg, E., Martti, A., Linden, A.-M., & Korpi, E. R. (2022) · Journal of Psychopharmacology · doi:10.1177/02698811221104641 · Cited by 24
“Beyond the previously suggested interplay between the mGlu2/3 receptors and 5-HT2A receptor (González-Maeso et al., 2008; Toneatti et al., 2020), it was recently shown that psilocybin can recover the alcohol dependence-induced downregulation of mGlu2 expression in the infralimbic cortex in rats,…”
BackgroundPsychedelics: preclinical insights provide directions for future research
Gumpper, R. H., & Roth, B. L. (2023) · Neuropsychopharmacology · doi:10.1038/s41386-023-01567-7 · Cited by 21
“This group has also reported that a heterodimeric complex between mGluR2 metabotropic glutamate and 5-HT 2A receptors may be responsible for these actions [108 – 110].”
BackgroundA suite of engineered mice for interrogating psychedelic drug actions
Chiu, Y.-T., Deutch, A. Y., Wang, W., Schmitz, G. P., Huang, K. L., Koçak, D. D., Llorach, P., Bowyer, K., Liu, B., Sciaky, N., et al. (2026) · Nature Neuroscience · doi:10.1038/s41593-026-02375-0 · Cited by 24
Wierońska, J. M., Stachowicz, K., Brański, P., Pałucha-Poniewiera, A., & Pilc, A. (2011) · Neuropharmacology · doi:10.1016/j.neuropharm.2011.07.042 · Cited by 20
“If those complexes are expressed on axon terminals, it may be possible that ritanserin changes the affinity of orthosteric agonist/PAM to its binding site at the receptor, as it was shown for DOI, a 5-HT2A agonist (González-Maeso et al., 2008), but the question is open for further investigations.”
Ago, Y., Araki, R., Yano, K., Hiramatsu, N., Kawasaki, T., Chaki, S., Nakazato, A., Onoe, H., Hashimoto, H., Baba, A., et al. (2011) · Psychopharmacology · doi:10.1007/s00213-011-2295-3 · Cited by 20
“On the other hand, González-Maeso et al. (2008) report that the mGlu2 receptors interact with the 5-HT2A receptors to form functional and physiological complexes in brain cortex.”
BackgroundRole of mGlu2 in the 5-HT2A receptor-dependent antipsychotic activity of clozapine in mice
Hideshima, K. S., Hojati, A., Saunders, J. M., On, D. M., Revenga, M. D. L. F., Shin, J. M., Sánchez-González, A., Dunn, C. M., Pais, A. B., Pais, A. C., et al. (2018) · Psychopharmacology · doi:10.1007/s00213-018-5015-4 · Cited by 23
Self-citationPresynaptic Release-regulating Metabotropic Glutamate Receptors: An Update
Olivero, G., Vergassola, M., Cisani, F., Roggeri, A., & Pittaluga, A. (2019) · Current Neuropharmacology · doi:10.2174/1570159x17666191127112339 · Cited by 20
“This receptorreceptor cross-talk was firstly shown to occur in the prefrontal cortex of mammals [129], where it was proposed as a functional mechanism through which glutamate modulates the efficiency of serotonin receptors [126, 130-132].”
BackgroundBack to the Future — The Therapeutic Potential of Psychedelic Drugs
Lieberman, J. A. (2021) · New England Journal of Medicine · doi:10.1056/nejme2102835 · Cited by 20
Family a GPCR heteromers in animal models
González‐Maeso, J. (2014) · Frontiers in Pharmacology · doi:10.3389/fphar.2014.00226 · Cited by 20
“For example, it has been shown that drugs that activate the Gq/11-coupled 5-HT2A receptor induce both Gq/11- and Gi/o-dependent signaling in HEK293 cells co-expressing 5-HT2A and the Gi/o-coupled mGlu2 receptor as a GPCR heteromer (Gonzalez-Maeso et al., 2008).”
BackgroundSelf-citationDevelopmental expression of mGlu2 and mGlu3 in the mouse brain
McOmish, C. E., Demireva, E. Y., & Gingrich, J. A. (2016) · Gene Expression Patterns · doi:10.1016/j.gep.2016.10.001 · Cited by 19
“Receptors of the mGlu2/3 class can heterodimerize with each other and with o ther receptors (Gonzalez-Maeso et al., 2008; Doumazane et al., 2011), controlling release of GAB A, monoamines and other neuropeptides (Cartmell et al.”
BackgroundSelf-citationZhang, G., Cinalli, D. A., & Stackman, R. W. (2017) · Hippocampus · doi:10.1002/hipo.22712 · Cited by 20
“Visual hallucinations occurring in Parkinson’s disease (Huot et al., 2010) and schizophrenia (Gonzalez-Maeso et al., 2008) have also been related to 5- HT2AR overexpression in temporal cortex.”
BackgroundAllosteric Molecular Switches in Metabotropic Glutamate Receptors
Orgován, Z., Ferenczy, G. G., & Keserű, G. M. (2020) · ChemMedChem · doi:10.1002/cmdc.202000444 · Cited by 20
Frouni, I., Kwan, C., Nuara, S. G., Belliveau, S., Kang, W., Hamadjida, A., Bédard, D., Gourdon, J. C., & Huot, P. (2021) · Journal of Neural Transmission · doi:10.1007/s00702-020-02287-8 · Cited by 19
“5-HT2A and mGlu2 receptors were shown to assemble in a functional hetero-complex (Gonzalez-Maeso et al. 2008; Delille et al. 2012) that regulates psychosis and the anti-psychotic action of 5-HT2A antagonists, with 5-HT2A antagonism and mGlu2 activation eliciting complementary effects at the down-stream signalling leve…”
BackgroundAndrovičová, R., Pfaus, J. G., & Ovsepian, S. V. (2021) · Neuroscience Letters · doi:10.1016/j.neulet.2021.136038 · Cited by 21
“Serotonergic and muscarinic cholinergic systems are also of relevance to schizophrenia, being involved in perception/sensory gating abnormalities [47] and cognitive deficit [48], respectively.”
Background
Metadata
- Authors
- González-Maeso, J., Ang, R. L., Yuen, T., Chan, P., Weisstaub, N. V., López-Giménez, J. F., Zhou, M., Okawa, Y., Callado, L. F., Milligan, G., Gingrich, J. A., Filizola, M., Meana, J. J., & Sealfon, S. C.
- Affiliations
- University of the Basque Country (ES)
- University of Glasgow (GB)
- New York State Psychiatric Institute (US)
- Icahn School of Medicine at Mount Sinai (US)
- Corresponding author
- Sealfon, Stuart C.
- ORCID
- Venue
- Nature
- Published
- 2008-02-24
- Volume
- 452
- Issue
- 7183
- Pages
- 93-97
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC2743172
- OpenAlex
- W2024942419
- Cited by
- 803
- References
- 44
- Citations by year
- 2026: 18 · 2025: 21 · 2024: 23 · 2023: 34 · 2022: 44 · 2021: 38 · 2020: 36 · 2019: 33 · 2018: 45 · 2017: 44 · 2016: 51 · 2015: 37 · 2014: 52 · 2013: 62 · 2012: 71
- FWCI
- 27.83
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- ENLIGHTEN (Jurnal Bimbingan dan Konseling Islam) (submittedVersion)
- Funders
- National Institute of Mental Health (U01MH083545)
- National Institute on Drug Abuse (T32DA007135, P01DA012923)
- National Institute of General Medical Sciences (T32GM062754)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Receptor Mechanisms and Signaling
- Keywords
- 5-HT2A receptor, mGluR2, metabotropic glutamate receptors, receptor complex, schizophrenia, psychosis, hallucinogens, LSD, psilocybin, cortical dysfunction, antipsychotic drug targets, postmortem brain
- MeSH terms
- Animals, Brain, Cell Line, Cells, Cultured, Hallucinogens, Humans, Models, Molecular, Protein Binding, Psychotic Disorders, Schizophrenia, Signal Transduction, Down-Regulation, Up-Regulation, Protein Structure, Tertiary, Receptors, Metabotropic Glutamate, Receptor, Serotonin, 5-HT2A, Multiprotein Complexes, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.